Home » Reports » Broker Ratings » GlaxoSmithKline plc 9.5% Potential Upside Indicated by Jefferies International
broker ratings

GlaxoSmithKline plc 9.5% Potential Upside Indicated by Jefferies International

GlaxoSmithKline plc using EPIC/TICKER code (LON:GSK) has had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘BUY’ this morning by analysts at Jefferies International. GlaxoSmithKline plc are listed in the Health Care sector within UK Main Market. Jefferies International have set a target price of 1730 GBX on its stock. This would indicate that the analyst believes there is a potential upside of 9.5% from today’s opening price of 1580 GBX. Over the last 30 and 90 trading days the company share price has increased 34.8 points and increased 155.6 points respectively. The 52 week high share price is 1632 GBX while the 52 week low for the share price is 1179.39 GBX.

GlaxoSmithKline plc has a 50 day moving average of 1,528.39 GBX and the 200 Day Moving Average price is recorded at 1,408.86. There are currently 4,959,866,880 shares in issue with the average daily volume traded being 9,518,787. Market capitalisation for LON:GSK is £77,398,242,705 GBP.